Stereotaxis has won European CE mark approval for its MaGiC ablation catheter, a robotically navigated device for the ...
The global cardiovascular devices market, valued at US$72.83 billion in 2023, is forecasted to grow at a robust CAGR of 7.3%, ...
Medtronic's next-gen renal denervation catheter and procedure are in the works to advance the FDA-approved Symplicity Spyral ...
Stereotaxis said today that it has secured CE mark approval for its Magic robotically-navigated magnetic ablation catheter.
Stereotaxis’ MAGiC catheter is a robotically-navigated magnetic ablation catheter designed to perform cardiac ablation procedures that treat heart arrhythmia. The MAGiC catheter was developed based on ...
PROVIDENCE — Katelyn Holt has been a nurse for over a decade. Throughout her career, she has noticed that the catheters her patients receive fall short. A few years ago, Holt was driving home ...
Catheter Precision, Inc. (NYSE American:VTAK), a US based medical device company focused on developing technologically advanced products for the cardiac electrophysiology market announced their ...